Chronic hepatitis C infection in children

Area of Science:

• Pediatric infectious diseases
• Hepatology
• Virology

Background:

• Hepatitis C virus (HCV) infection presents unique challenges in pediatric populations regarding transmission, disease progression, and treatment response.
• While most infected children develop chronic hepatitis, the disease course is typically milder than in adults.

Purpose of the Study:

• To review the distinct characteristics of Hepatitis C virus infection in children, including transmission routes, natural history, and treatment outcomes.
• To highlight current understanding and future directions for managing pediatric HCV.

Main Methods:

• Review of existing literature on pediatric Hepatitis C virus infection.
• Analysis of transmission dynamics, including perinatal and other routes.
• Evaluation of disease progression and histopathological findings.
• Assessment of current and emerging treatment strategies.

Main Results:

• Maternal-infant transmission is the predominant risk factor for pediatric HCV acquisition.
• Vertically acquired and post-transfusion HCV infections may progress more rapidly to advanced liver disease compared to other transmission routes.
• Combination therapy with peginterferon-alfa-2b and ribavirin shows promising tolerability and efficacy in children, though not yet FDA-approved.

Conclusions:

• Hepatitis C virus infection in children requires specialized consideration due to differences in transmission and disease course.
• While current treatments show promise, further randomized controlled trials are essential to optimize pediatric HCV management.